ITRM vs TT · rev $390.0K vs P/E 36, rev $21.32B
Iterum Therapeutics PLC (ITRM) versus Trane Technologies plc (TT) — a side-by-side from cached financials, not a winner call.
Iterum Therapeutics PLC (ITRM) is a biotechnology company listed on US.
Trane Technologies plc (TT) is a building products & equipment company listed on NYSE.
Latest reported ITRM revenue for 2025-09-30 was $390.0K. Net income was -$20.4M. ITRM currently screens at market cap $38.6M.
Latest reported TT revenue for 2025-12-31 was $21.32B. Net income was $2.92B. Revenue was up 7.5% from 2024-12-31 to 2025-12-31. TT currently screens at market cap $104.45B and trailing P/E 36.2.
ITRM currently screens at market cap $38.6M. TT currently screens at market cap $104.45B and trailing P/E 36.2.
Not investment advice. Open the ITRM and TT stock pages for the full models.
Not investment advice.